Chargement en cours...
Novel glutamatergic drugs for the treatment of mood disorders
Mood disorders are common and debilitating, resulting in a significant public health burden. Current treatments are only partly effective and patients who have failed to respond to trials of existing antidepressant agents (eg, those who suffer from treatment-resistant depression [TRD]) require innov...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3747027/ https://ncbi.nlm.nih.gov/pubmed/23976856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S36689 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|